--- title: 20 New FDA Biological Approvals in 2019 description: A comprehensive table of FDA CBER's 20 new biological approvals and their corresponding approval dates, intended uses, and companies. image: https://blog.scalehealth.com/hubfs/022-20Drugs-1.jpg --- [![Sierra Labs](https://blog.scalehealth.com/hubfs/Sierralabs_January2019%20Theme/Images/sierra-labs-logo.png)](https://www.sierralabs.com/) - Products - [Sierra Policies & Procedures](https://www.sierralabs.com/policies-procedures) - [Sierra Document Automation](https://www.sierralabs.com/document-automation) - [Sierra Quality Management](https://www.sierralabs.com/quality-management) - [Sierra GxP Cloud Validation](https://www.sierralabs.com/cloud-validation) - [Services](https://www.sierralabs.com/services) - [About Us](https://www.sierralabs.com/about) - [Partner](https://campaign.sierralabs.com/partner-with-sierra-labs) - [Blog](https://blog.scalehealth.com) - [Contact Us](https://www.sierralabs.com/document-automation/#contact-us) [Contact Us](https://www.sierralabs.com/document-automation/#contact-us)   ## Sierra Labs Blog This is a search field with an auto-suggest feature attached. - There are no suggestions because the search field is empty. # 20 New FDA Biological Approvals in 2019 Posted by [Sierra Labs](https://blog.scalehealth.com/author/sierra-labs) on Jan 14, 2020, 1:10:01 PM - [Tweet](https://twitter.com/share) A comprehensive table of CBER's 20 new biological approvals and their corresponding approval dates, intended uses, and companies. ![022-20Drugs-1](https://blog.scalehealth.com/hs-fs/hubfs/022-20Drugs-1.jpg?width=920&name=022-20Drugs-1.jpg) As promised in our last blog, [48 New Drug FDA Approvals in 2019](https://blog.scalehealth.com/48-new-drug-fda-approvals-in-2019), here are the remaining new drugs approved by FDA's Center for Biologics Evaluation and Research (CBER) that were excluded from the previous list! This listing contains vaccines, allergenic products, blood and blood products, plasma derivatives, cellular and gene therapy products, and other products approved in 2019 by CBER. This list excludes molecular entities approved by FDA’s Center for Drug Evaluation and Research (CDER). To view CDER's list of 48 new drugs in 2019, view our [previous post](https://blog.scalehealth.com/48-new-drug-fda-approvals-in-2019). We have organized the 20 new biological drugs chronologically in a list below based on their corresponding approval dates. Enjoy!   | **Trade Name** | **Proper Name** | **Approval Date** | **Intended Use** | **Company** | | --- | --- | --- | --- | --- | | 1. Procleix Babesia Assay | Procleix Babesia Assay | Jan. 24, 2019 | Qualitative in vitro nucleic acid amplification test for the detection of RNA from Babesia species (B. microti, B. duncani,  B. divergens, and B. venatorum) in whole blood specimens. Screen individual human donors (whole blood, blood components, organ, and tissue).  Screen cadaveric (non-heart- beating) donors for B. microti. | ![logo](https://www.grifols.com/grifolscom-theme/images/logo/logo.png) | | 2. ESPEROCT | Antihemophilic Factor (Recombinant), GlycoPEGylated-exei | Feb. 19, 2019 | Use in adults and children with hemophilia A for: (1) on-demand treatment and control of bleeding episodes, (2) perioperative management of bleeding, and (3) routine prophylaxis to reduce the frequency of bleeding episodes. | ![novo-logo-dhpx.image.136.0](https://www.novonordisk-us.com/content/dam/Denmark/HQ/Commons/images/novo-logo-dhpx.image.136.0.png) | | 3. ASCENIV | Immune Globulin Intravenous, Human-slra | April 1, 2019 | Treat primary humoral immunodeficiency for adults and adolescents (12 to 17 years of age) | ![header-logo](https://d1io3yog0oux5.cloudfront.net/_8be84a3d6664a51cfeae187881a96c54/admabiologics/files/theme/images/header-logo.png) | | 4. Gamma-clone® Blood Grouping Reagent, Anti-k (Monoclonal) | Blood Grouping Reagent, Anti-k (Monoclonal)(IgG) | April 18, 2019 | Detect the k (KEL2) antigen on red blood cells by indirect agglutination tube test | ![WelcomeToImmucor](https://www.immucor.com/en-us/PublishingImages/WelcomeToImmucor.gif) | | 5. Gamma-clone® Blood Grouping Reagent, Anti-Cw (Monoclonal) | Blood Grouping Reagent, Anti-Cw (Monoclonal) | April 18, 2019 | Detect the Cw(RH8) antigen on red blood cells by direct agglutination using a tube method. | ![WelcomeToImmucor](https://www.immucor.com/en-us/PublishingImages/WelcomeToImmucor.gif) | | 6. Gamma-clone® Blood Grouping Reagent, Anti-Fyb (Monoclonal) | Blood Grouping Reagent, Anti-Fyb (Monoclonal) | April 18, 2019 | Detect the Fyb (FY2) antigen on red blood cells by direct agglutination using a tube method. | ![WelcomeToImmucor](https://www.immucor.com/en-us/PublishingImages/WelcomeToImmucor.gif) | | 7. Blood Grouping Reagent, Anti-k (Monoclonal) (IgG) (For Further Manufacturing Use) | N/A | April 18, 2019 | A standardized raw material for the manufacture of finished Anti-k blood typing reagents/devices for *in vitro* use | ![logo-rb-ms](https://www.emdmillipore.com/INTERSHOP/static/WFS/Merck-US-Site/-/Merck/en_CA/system/logo-rb-ms.png) | | 8. DENGVAXIA | Dengue Tetravalent Vaccine, Live | May 1, 2019 | Prevent dengue disease caused by dengue virus serotypes 1, 2, 3 and 4 in individuals 9 through 16 years of age with laboratory-confirmed previous dengue infection and living in endemic areas. | ![sanofi-aventis-logo-vector](https://seeklogo.net/wp-content/uploads/2011/06/sanofi-aventis-logo-vector.png) | | 9. ZOLGENSMA | onasemnogene abeparvovec | May 24, 2019 | Treat pediatric patients less than two years of age with spinal muscular atrophy (SMA) with bi-allelic mutations in the *survival motor neuron 1 (SMN1)* gene. | ![140px-AveXis.svg](https://upload.wikimedia.org/wikipedia/en/thumb/7/7b/AveXis.svg/140px-AveXis.svg.png) | | 10. Abbott Alinity s HBsAg and Abbott Alinity s HBsAg Confirmatory | Antibody to Hepatitis B Surface Antigen (Mouse Monoclonal IgG and IgM) and Antibody to Hepatitis B Surface Antigen (Sheep) | June 14, 2019 | Detect hepatitis B surface antigen (HBsAg) in human serum and plasma specimens on the Alinity s System. Screen individual human donors (whole blood, blood components, organ, and tissue) for the presence of HBsAG.  Test serum and plasma specimens to screen live or cadaveric (non-heart-beating) organ donors. | ![abbott](https://a.storyblok.com/f/58406/500x126/aa693a00d7/abbott.png) | | 11. Alinity s HTLV I/II | Human T-Lymphotropic Virus Types I and II (E coli, Recombinant) Antigen and Synthetic Peptides | June 26, 2019 | Detect antibodies to human T-lymphotropic virus Type I and/or human T-lymphotropic virus Type II (anti-HTLV I/HTLV II) in human serum and plasma specimens on the Alinity s System. Screen individual human donors (whole blood, blood components, organ, and tissue) for the presence of anti‑HTLV I/HTLV II. Test serum and plasma specimens to screen live or cadaveric (non-heart-beating) organ donors. | ![abbott](https://a.storyblok.com/f/58406/500x126/aa693a00d7/abbott.png) | | 12. XEMBIFY | Immune Globulin Subcutaneous (Human) | July 3, 2019 | Treat Primary Humoral Immunodeficiency (PI) in patients 2 years of age and older. | ![logo](https://www.grifols.com/grifolscom-theme/images/logo/logo.png) | | 13. Alinity s Anti-HCV | Hepatitis C-virus Encoded Antigens (Recombinant c100-3, HCr43) | July 9, 2019 | Detect antibodies to hepatitis C virus (HCV) in human serum and plasma specimens on the Alinity s System. Screen individual human donors (whole blood, blood components, organ, and tissue) for the presence of anti-HCV. Test serum and plasma specimens to screen live or cadaveric (non-heart-beating) organ donors. | ![abbott](https://a.storyblok.com/f/58406/500x126/aa693a00d7/abbott.png) | | 14. Alinity s HIV Ag/Ab Combo Reagent Kit | Human Immunodeficiency Virus Types 1 and 2 (E. coli, B. megaterium, Recombinant) Antigen, Antibody (p24) and Synthetic Peptide | July 23, 2019 | Detect human immunodeficiency virus (HIV) p24 antigen and antibodies to HIV type 1 (HIV-1 group M and group O) and/or type 2 (HIV-2) in human serum and plasma specimens on the Alinity s System. Screen individual human donors (whole blood, blood components, organ, and tissue) for the presence of antiHIV-1/HIV-2 and HIV-1 p24 antigen. Test serum and plasma specimens to screen live or cadaveric (non-heart-beating) organ donors. | ![abbott](https://a.storyblok.com/f/58406/500x126/aa693a00d7/abbott.png) | | 15. Alinity s Anti-HBc | Hepatitis B Virus Core Antigen (E.coli, Recombinant) | Aug. 2, 2019 | Detect antibody to hepatitis B core antigen (anti-HBc) in human serum and plasma specimens on the Alinity s System. Screen individual human donors (whole blood, blood components, organ, and tissue) for the presence of anti-HBc. Test serum and plasma specimens to screen live or cadaveric (non-heart-beating) organ donors. | ![abbott](https://a.storyblok.com/f/58406/500x126/aa693a00d7/abbott.png) | | 16. N/A | Blood Grouping Reagent, Anti A (Muring Monoclonal) (FFMU) | Aug. 12, 2019 | Further manufacture Blood Grouping Reagents. | ![Logo_Diagast](https://www.diagast-support.com/Images/Logo_Diagast.png) | | 17. Alinity s Chagas | Trypanosoma cruzi (E. coli, Recombinant) Antigen | Aug. 15, 2019 | Detect antibodies to T. cruzi (the causative agent of Chagas disease) in human serum and plasma specimens on the Alinity s System. Screen individual human donors (whole blood, blood components, organ, and tissue) for the presence of antibodies to T. cruzi. Test serum and plasma specimens to screen live or cadaveric (non-heart-beating) organ donors. | ![abbott](https://a.storyblok.com/f/58406/500x126/aa693a00d7/abbott.png) | | 18. Geenius HIV 1/2 Supplementary Assay | Human Immunodeficiency Virus Types 1 and 2 (Recombinant and Synthetic Peptides) | Aug. 26, 2019 | Single-use immunochromatographic assay to confirm and differentiate individual antibodies to Human Immunodeficiency Virus Types 1 and 2 (HIV-1 and HIV-2) in serum or plasma samples (EDTA, lithium heparin, sodium citrate, and CPD) from blood donors. The results of the Geenius HIV 1/2 Supplemental Assay are read and interpreted only with the Geenius Reader with dedicated software. | ![204-40_400](https://www.environmental-expert.com/files/98376/images/204-40_400.png) | | 19. cobas® Babesia | cobas Babesia test for use on the cobas 6800/8800 Systems | Aug. 29, 2019 | Test for use on the cobas® 6800/8800 Systems is a qualitative in vitro nucleic acid screening test for the direct detection of *Babesia* DNA and RNA in whole blood. | ![1280px-Roche_Logo.svg](https://upload.wikimedia.org/wikipedia/commons/thumb/1/17/Roche_Logo.svg/1280px-Roche_Logo.svg.png) | | 20. JYNNEOS | Modified Vaccinia Ankara - Bavarian Nordic (MVA-BN) | Sept. 24, 2019 | Prevent smallpox and monkeypox disease in adults 18 years of age and older determined to be at high risk for smallpox or monkeypox infection. | ![1200px-Bavarian_Nordic_logo.svg](https://upload.wikimedia.org/wikipedia/commons/thumb/6/63/Bavarian_Nordic_logo.svg/1200px-Bavarian_Nordic_logo.svg.png) |   **Are you a Healthcare or Life Science company in need of a Quality Management System (QMS) or Cloud Validation System?** **Check out our free White Papers below to learn more!** **[![QMS White Paper](https://hubspot-no-cache-na2-prod.s3.amazonaws.com/cta/default/5229980/2758d72e-d3e6-4c97-a8af-10a702e5f0bf.png)](https://hubspot-cta-redirect-na2-prod.s3.amazonaws.com/cta/redirect/5229980/2758d72e-d3e6-4c97-a8af-10a702e5f0bf) [![Cloud White Paper](https://hubspot-no-cache-na2-prod.s3.amazonaws.com/cta/default/5229980/b50fbb5c-83e4-4fce-af77-3fd255eaa4c6.png)](https://hubspot-cta-redirect-na2-prod.s3.amazonaws.com/cta/redirect/5229980/b50fbb5c-83e4-4fce-af77-3fd255eaa4c6)** Yes, compliance can really be that simple!   Sources: Center for Biologics Evaluation and Research, FDA. “2019 Biological License Application Approvals.” *U.S. Food and Drug Administration*, FDA, 2019, www.fda.gov/vaccines-blood-biologics/development-approval-process-cber/2019-biological-license-application-approvals. Topics: [FDA](https://blog.scalehealth.com/tag/fda), [Compliance](https://blog.scalehealth.com/tag/compliance), [CDER](https://blog.scalehealth.com/tag/cder), [New Drugs](https://blog.scalehealth.com/tag/new-drugs), [Center for Biologics Evaluation and Research](https://blog.scalehealth.com/tag/center-for-biologics-evaluation-and-research), [Drug Approval](https://blog.scalehealth.com/tag/drug-approval), [FDA Approval](https://blog.scalehealth.com/tag/fda-approval) ## Featured posts ### Topics - [FDA (42)](https://blog.scalehealth.com/tag/fda) - [QMS (31)](https://blog.scalehealth.com/tag/qms) - [Compliance (28)](https://blog.scalehealth.com/tag/compliance) - [Medical Device (27)](https://blog.scalehealth.com/tag/medical-device) - [Medical Device Company (26)](https://blog.scalehealth.com/tag/medical-device-company) - [SaMD (26)](https://blog.scalehealth.com/tag/samd) - [Data Security (17)](https://blog.scalehealth.com/tag/data-security) - [Regulations (17)](https://blog.scalehealth.com/tag/regulations) - [21 CFR Part 820 (15)](https://blog.scalehealth.com/tag/21-cfr-part-820) - [Medical Devices (15)](https://blog.scalehealth.com/tag/medical-devices) - [ISO (14)](https://blog.scalehealth.com/tag/iso) - [FDA Approval (13)](https://blog.scalehealth.com/tag/fda-approval) - [Agile (12)](https://blog.scalehealth.com/tag/agile) - [Data Privacy (12)](https://blog.scalehealth.com/tag/data-privacy) - [FDA Regulation (12)](https://blog.scalehealth.com/tag/fda-regulation) - [ISO 13485 (11)](https://blog.scalehealth.com/tag/iso-13485) - [SaMD Development (11)](https://blog.scalehealth.com/tag/samd-development) - [CFR Part 820 (10)](https://blog.scalehealth.com/tag/cfr-part-820) - [Data Requirements (10)](https://blog.scalehealth.com/tag/data-requirements) - [Document Controls (10)](https://blog.scalehealth.com/tag/document-controls) - [FDA Pre-Sub (10)](https://blog.scalehealth.com/tag/fda-pre-sub) - [Health Technology (10)](https://blog.scalehealth.com/tag/health-technology) - [Regulatory Pathway (10)](https://blog.scalehealth.com/tag/regulatory-pathway) - [AI (9)](https://blog.scalehealth.com/tag/ai) - [Documentation (9)](https://blog.scalehealth.com/tag/documentation) - [GxP Cloud (9)](https://blog.scalehealth.com/tag/gxp-cloud) - [Quality System Regulation (9)](https://blog.scalehealth.com/tag/quality-system-regulation) - [Technology (9)](https://blog.scalehealth.com/tag/technology) - [Validated Cloud (9)](https://blog.scalehealth.com/tag/validated-cloud) - [risk (9)](https://blog.scalehealth.com/tag/risk) - [Cloud (8)](https://blog.scalehealth.com/tag/cloud) - [FDA Audit (8)](https://blog.scalehealth.com/tag/fda-audit) - [GxP (8)](https://blog.scalehealth.com/tag/gxp) - [Health Data (8)](https://blog.scalehealth.com/tag/health-data) - [ISO 13485:2016 (8)](https://blog.scalehealth.com/tag/iso-134852016) - [ISO 14971 (8)](https://blog.scalehealth.com/tag/iso-14971) - [Manufacturing (8)](https://blog.scalehealth.com/tag/manufacturing) - [PHI (8)](https://blog.scalehealth.com/tag/phi) - [Personal Health Information (8)](https://blog.scalehealth.com/tag/personal-health-information) - [Conformity (7)](https://blog.scalehealth.com/tag/conformity) - [Healthcare (7)](https://blog.scalehealth.com/tag/healthcare) - [Life Science QMS (7)](https://blog.scalehealth.com/tag/life-science-qms) - [Medical Solutions (7)](https://blog.scalehealth.com/tag/medical-solutions) - [Product Development (7)](https://blog.scalehealth.com/tag/product-development) - [Regulatory Strategy (7)](https://blog.scalehealth.com/tag/regulatory-strategy) - [SaMD QMS (7)](https://blog.scalehealth.com/tag/samd-qms) - [Software Requirement Specification (7)](https://blog.scalehealth.com/tag/software-requirement-specification) - [Standards (7)](https://blog.scalehealth.com/tag/standards) - [21 CFR (6)](https://blog.scalehealth.com/tag/21-cfr) - [Quality Management System (6)](https://blog.scalehealth.com/tag/quality-management-system) - [Quality Processes (6)](https://blog.scalehealth.com/tag/quality-processes) - [Regulatory Roadmap (6)](https://blog.scalehealth.com/tag/regulatory-roadmap) - [eHealth (6)](https://blog.scalehealth.com/tag/ehealth) - [21 CFR Part 11 (5)](https://blog.scalehealth.com/tag/21-cfr-part-11) - [Artificial Intelligence (5)](https://blog.scalehealth.com/tag/artificial-intelligence) - [CAPA (5)](https://blog.scalehealth.com/tag/capa) - [COVID19 (5)](https://blog.scalehealth.com/tag/covid19) - [Design Controls (5)](https://blog.scalehealth.com/tag/design-controls) - [Digital Health (5)](https://blog.scalehealth.com/tag/digital-health) - [Health Tech (5)](https://blog.scalehealth.com/tag/health-tech) - [Jira Cloud (5)](https://blog.scalehealth.com/tag/jira-cloud) - [Jira QMS (5)](https://blog.scalehealth.com/tag/jira-qms) - [New Drugs (5)](https://blog.scalehealth.com/tag/new-drugs) - [QMS healthcare (5)](https://blog.scalehealth.com/tag/qms-healthcare) - [Sierra QMS (5)](https://blog.scalehealth.com/tag/sierra-qms) - [training management (5)](https://blog.scalehealth.com/tag/training-management) - [Automation (4)](https://blog.scalehealth.com/tag/automation) - [Biopharma (4)](https://blog.scalehealth.com/tag/biopharma) - [Business Associates (4)](https://blog.scalehealth.com/tag/business-associates) - [Communication (4)](https://blog.scalehealth.com/tag/communication) - [Covered Entities (4)](https://blog.scalehealth.com/tag/covered-entities) - [Data Integrity (4)](https://blog.scalehealth.com/tag/data-integrity) - [Development Change (4)](https://blog.scalehealth.com/tag/development-change) - [Drug Approval (4)](https://blog.scalehealth.com/tag/drug-approval) - [GAMP5 (4)](https://blog.scalehealth.com/tag/gamp5) - [HIPAA (4)](https://blog.scalehealth.com/tag/hipaa) - [HIPAA Compliance (4)](https://blog.scalehealth.com/tag/hipaa-compliance) - [Health Applications (4)](https://blog.scalehealth.com/tag/health-applications) - [Integrated QMS (4)](https://blog.scalehealth.com/tag/integrated-qms) - [Medical Device Startups (4)](https://blog.scalehealth.com/tag/medical-device-startups) - [Pre-Submission (4)](https://blog.scalehealth.com/tag/pre-submission) - [Product Lifecycle (4)](https://blog.scalehealth.com/tag/product-lifecycle) - [Quality Roadmap (4)](https://blog.scalehealth.com/tag/quality-roadmap) - [Recall (4)](https://blog.scalehealth.com/tag/recall) - [Regulatory Approach (4)](https://blog.scalehealth.com/tag/regulatory-approach) - [Remote Work (4)](https://blog.scalehealth.com/tag/remote-work) - [Scale-ups (4)](https://blog.scalehealth.com/tag/scale-ups) - [Software (4)](https://blog.scalehealth.com/tag/software) - [Streamline Workflows (4)](https://blog.scalehealth.com/tag/streamline-workflows) - [document management (4)](https://blog.scalehealth.com/tag/document-management) - [ePHI (4)](https://blog.scalehealth.com/tag/ephi) - [510(k) (3)](https://blog.scalehealth.com/tag/510k) - [COVID-19 Solution (3)](https://blog.scalehealth.com/tag/covid-19-solution) - [Case Study (3)](https://blog.scalehealth.com/tag/case-study) - [Compliance Process (3)](https://blog.scalehealth.com/tag/compliance-process) - [Cybersecurity (3)](https://blog.scalehealth.com/tag/cybersecurity) - [DTx (3)](https://blog.scalehealth.com/tag/dtx) - [Design Verification (3)](https://blog.scalehealth.com/tag/design-verification) - [Document Automation Tools (3)](https://blog.scalehealth.com/tag/document-automation-tools) - [FDA Standard (3)](https://blog.scalehealth.com/tag/fda-standard) - [GAMP (3)](https://blog.scalehealth.com/tag/gamp) - [HIPAA Checklist (3)](https://blog.scalehealth.com/tag/hipaa-checklist) - [Hardware-based (3)](https://blog.scalehealth.com/tag/hardware-based) - [IEC 62304 (3)](https://blog.scalehealth.com/tag/iec-62304) - [ISPE (3)](https://blog.scalehealth.com/tag/ispe) - [Iterative Process (3)](https://blog.scalehealth.com/tag/iterative-process) - [Life Science (3)](https://blog.scalehealth.com/tag/life-science) - [Medical Technology (3)](https://blog.scalehealth.com/tag/medical-technology) - [Pharma (3)](https://blog.scalehealth.com/tag/pharma) - [Predicate Device (3)](https://blog.scalehealth.com/tag/predicate-device) - [Product Requirements Document (3)](https://blog.scalehealth.com/tag/product-requirements-document) - [QMS for SaMD Startups (3)](https://blog.scalehealth.com/tag/qms-for-samd-startups) - [Risk Management (3)](https://blog.scalehealth.com/tag/risk-management) - [SOC (3)](https://blog.scalehealth.com/tag/soc) - [SOC 2 (3)](https://blog.scalehealth.com/tag/soc-2) - [SOP (3)](https://blog.scalehealth.com/tag/sop) - [SaMD Startups (3)](https://blog.scalehealth.com/tag/samd-startups) - [Software Development (3)](https://blog.scalehealth.com/tag/software-development) - [Telecare (3)](https://blog.scalehealth.com/tag/telecare) - [Telehealth (3)](https://blog.scalehealth.com/tag/telehealth) - [eQMS (3)](https://blog.scalehealth.com/tag/eqms) - [AWS (2)](https://blog.scalehealth.com/tag/aws) - [Audit Trails (2)](https://blog.scalehealth.com/tag/audit-trails) - [CDER (2)](https://blog.scalehealth.com/tag/cder) - [CE Marking (2)](https://blog.scalehealth.com/tag/ce-marking) - [CFR (2)](https://blog.scalehealth.com/tag/cfr) - [Center for Biologics Evaluation and Research (2)](https://blog.scalehealth.com/tag/center-for-biologics-evaluation-and-research) - [Center for Drug Evaluation and Research (2)](https://blog.scalehealth.com/tag/center-for-drug-evaluation-and-research) - [Clinical Evaluation (2)](https://blog.scalehealth.com/tag/clinical-evaluation) - [Corrective Action Preventive Action (2)](https://blog.scalehealth.com/tag/corrective-action-preventive-action) - [Document Automation (2)](https://blog.scalehealth.com/tag/document-automation) - [Document Control (2)](https://blog.scalehealth.com/tag/document-control) - [Documentation Automation (2)](https://blog.scalehealth.com/tag/documentation-automation) - [Electronic Records (2)](https://blog.scalehealth.com/tag/electronic-records) - [GMP (2)](https://blog.scalehealth.com/tag/gmp) - [General Controls (2)](https://blog.scalehealth.com/tag/general-controls) - [HITRUST (2)](https://blog.scalehealth.com/tag/hitrust) - [HITRUST CSF (2)](https://blog.scalehealth.com/tag/hitrust-csf) - [ML (2)](https://blog.scalehealth.com/tag/ml) - [Machine Learning (2)](https://blog.scalehealth.com/tag/machine-learning) - [New Draft (2)](https://blog.scalehealth.com/tag/new-draft) - [Pharmaceutical (2)](https://blog.scalehealth.com/tag/pharmaceutical) - [Pre-market approval (2)](https://blog.scalehealth.com/tag/pre-market-approval) - [QS (2)](https://blog.scalehealth.com/tag/qs) - [Risk Classification (2)](https://blog.scalehealth.com/tag/risk-classification) - [Risk Managment (2)](https://blog.scalehealth.com/tag/risk-managment) - [Sierra Policies (2)](https://blog.scalehealth.com/tag/sierra-policies) - [Sierra Services (2)](https://blog.scalehealth.com/tag/sierra-services) - [Standard Operating Procedure (2)](https://blog.scalehealth.com/tag/standard-operating-procedure) - [fda submission (2)](https://blog.scalehealth.com/tag/fda-submission) - [mHealth Wearables (2)](https://blog.scalehealth.com/tag/mhealth-wearables) - [rta (2)](https://blog.scalehealth.com/tag/rta) - [software as medical device (2)](https://blog.scalehealth.com/tag/software-as-medical-device) - [21 cfr 807 (1)](https://blog.scalehealth.com/tag/21-cfr-807) - [513G (1)](https://blog.scalehealth.com/tag/513g) - [AAMI TIR45 (1)](https://blog.scalehealth.com/tag/aami-tir45) - [AICPA (1)](https://blog.scalehealth.com/tag/aicpa) - [ANVISA (1)](https://blog.scalehealth.com/tag/anvisa) - [Agência Nacional de Vigilância Sanitária (1)](https://blog.scalehealth.com/tag/agência-nacional-de-vigilância-sanitária) - [Amazon Web Services (1)](https://blog.scalehealth.com/tag/amazon-web-services) - [Analytical Validation (1)](https://blog.scalehealth.com/tag/analytical-validation) - [Annex 11 (1)](https://blog.scalehealth.com/tag/annex-11) - [Australian Therapeutic Goods Administration (1)](https://blog.scalehealth.com/tag/australian-therapeutic-goods-administration) - [BLA (1)](https://blog.scalehealth.com/tag/bla) - [Backlog (1)](https://blog.scalehealth.com/tag/backlog) - [Biologic Approval (1)](https://blog.scalehealth.com/tag/biologic-approval) - [Business Goals (1)](https://blog.scalehealth.com/tag/business-goals) - [CGMP (1)](https://blog.scalehealth.com/tag/cgmp) - [Cannabis (1)](https://blog.scalehealth.com/tag/cannabis) - [Cannabis Compliance (1)](https://blog.scalehealth.com/tag/cannabis-compliance) - [Change Control (1)](https://blog.scalehealth.com/tag/change-control) - [Client Reference (1)](https://blog.scalehealth.com/tag/client-reference) - [Clinical Development (1)](https://blog.scalehealth.com/tag/clinical-development) - [Clinical Validation (1)](https://blog.scalehealth.com/tag/clinical-validation) - [Code Reviews (1)](https://blog.scalehealth.com/tag/code-reviews) - [Conference (1)](https://blog.scalehealth.com/tag/conference) - [Coronavirus (1)](https://blog.scalehealth.com/tag/coronavirus) - [Current Good Manufacturing Practice (1)](https://blog.scalehealth.com/tag/current-good-manufacturing-practice) - [Customer Complaint (1)](https://blog.scalehealth.com/tag/customer-complaint) - [Data Transfer (1)](https://blog.scalehealth.com/tag/data-transfer) - [Design Changes (1)](https://blog.scalehealth.com/tag/design-changes) - [Design History File (1)](https://blog.scalehealth.com/tag/design-history-file) - [Design Transfer (1)](https://blog.scalehealth.com/tag/design-transfer) - [Development Team (1)](https://blog.scalehealth.com/tag/development-team) - [Device Classification (1)](https://blog.scalehealth.com/tag/device-classification) - [Device Software Functions (1)](https://blog.scalehealth.com/tag/device-software-functions) - [Document Publishing (1)](https://blog.scalehealth.com/tag/document-publishing) - [Drug Manufacturing (1)](https://blog.scalehealth.com/tag/drug-manufacturing) - [EUA (1)](https://blog.scalehealth.com/tag/eua) - [Electronic Signatures (1)](https://blog.scalehealth.com/tag/electronic-signatures) - [Emergency Use Authorization (1)](https://blog.scalehealth.com/tag/emergency-use-authorization) - [Enforcement Discretion (1)](https://blog.scalehealth.com/tag/enforcement-discretion) - [Engineering (1)](https://blog.scalehealth.com/tag/engineering) - [Ethos Automated System (1)](https://blog.scalehealth.com/tag/ethos-automated-system) - [FDA Draft (1)](https://blog.scalehealth.com/tag/fda-draft) - [HHS (1)](https://blog.scalehealth.com/tag/hhs) - [Hand Sanitizer (1)](https://blog.scalehealth.com/tag/hand-sanitizer) - [Hardware Development (1)](https://blog.scalehealth.com/tag/hardware-development) - [IEC (1)](https://blog.scalehealth.com/tag/iec) - [IEC 60601 (1)](https://blog.scalehealth.com/tag/iec-60601) - [IEC 60601:1 (1)](https://blog.scalehealth.com/tag/iec-606011) - [IEC 62366  (1)](https://blog.scalehealth.com/tag/iec-62366) - [IFU (1)](https://blog.scalehealth.com/tag/ifu) - [IND (1)](https://blog.scalehealth.com/tag/ind) - [ISO 13485: 2003 (1)](https://blog.scalehealth.com/tag/iso-13485-2003) - [ISO90003:2004 (1)](https://blog.scalehealth.com/tag/iso900032004) - [Intellectual Property (1)](https://blog.scalehealth.com/tag/intellectual-property) - [International Electrotechnical Commission (1)](https://blog.scalehealth.com/tag/international-electrotechnical-commission) - [International Organization for Standardization (1)](https://blog.scalehealth.com/tag/international-organization-for-standardization) - [Jira Server (1)](https://blog.scalehealth.com/tag/jira-server) - [Key Terms (1)](https://blog.scalehealth.com/tag/key-terms) - [Labeling (1)](https://blog.scalehealth.com/tag/labeling) - [Liability (1)](https://blog.scalehealth.com/tag/liability) - [MDSAP (1)](https://blog.scalehealth.com/tag/mdsap) - [METRC (1)](https://blog.scalehealth.com/tag/metrc) - [MHLW/PMDA (1)](https://blog.scalehealth.com/tag/mhlw-pmda) - [Management Controls (1)](https://blog.scalehealth.com/tag/management-controls) - [Masks (1)](https://blog.scalehealth.com/tag/masks) - [Medical Device Single Audit Program (1)](https://blog.scalehealth.com/tag/medical-device-single-audit-program) - [Medical Marijuana (1)](https://blog.scalehealth.com/tag/medical-marijuana) - [Ministry of Health, Labour and Welfare (1)](https://blog.scalehealth.com/tag/ministry-of-health-labour-and-welfare) - [Myths (1)](https://blog.scalehealth.com/tag/myths) - [New Approach Directives (1)](https://blog.scalehealth.com/tag/new-approach-directives) - [New Drug Application (1)](https://blog.scalehealth.com/tag/new-drug-application) - [Nonconformity (1)](https://blog.scalehealth.com/tag/nonconformity) - [PCCP (1)](https://blog.scalehealth.com/tag/pccp) - [PRD (1)](https://blog.scalehealth.com/tag/prd) - [Pandemic (1)](https://blog.scalehealth.com/tag/pandemic) - [Part 11 (1)](https://blog.scalehealth.com/tag/part-11) - [Part 820.30 (1)](https://blog.scalehealth.com/tag/part-820-30) - [Performance Tests (1)](https://blog.scalehealth.com/tag/performance-tests) - [Preliminary Screening (1)](https://blog.scalehealth.com/tag/preliminary-screening) - [Project Deliverables (1)](https://blog.scalehealth.com/tag/project-deliverables) - [Project Timeline (1)](https://blog.scalehealth.com/tag/project-timeline) - [QA/RA (1)](https://blog.scalehealth.com/tag/qa-ra) - [QMSR (1)](https://blog.scalehealth.com/tag/qmsr) - [Regulatory Options (1)](https://blog.scalehealth.com/tag/regulatory-options) - [SRS (1)](https://blog.scalehealth.com/tag/srs) - [SaMD Risk Classification (1)](https://blog.scalehealth.com/tag/samd-risk-classification) - [SaMD for QMS (1)](https://blog.scalehealth.com/tag/samd-for-qms) - [SiMD (1)](https://blog.scalehealth.com/tag/simd) - [Software Architecture (1)](https://blog.scalehealth.com/tag/software-architecture) - [Sprints (1)](https://blog.scalehealth.com/tag/sprints) - [Substantial Equivalence (1)](https://blog.scalehealth.com/tag/substantial-equivalence) - [TGA (1)](https://blog.scalehealth.com/tag/tga) - [TSC (1)](https://blog.scalehealth.com/tag/tsc) - [Trust Services Criteria (1)](https://blog.scalehealth.com/tag/trust-services-criteria) - [Valid Clinical Association (1)](https://blog.scalehealth.com/tag/valid-clinical-association) - [Validation Testing (1)](https://blog.scalehealth.com/tag/validation-testing) - [Waterfall Method (1)](https://blog.scalehealth.com/tag/waterfall-method) - [Webinar (1)](https://blog.scalehealth.com/tag/webinar) - [Workflow Transitions (1)](https://blog.scalehealth.com/tag/workflow-transitions) - [abbreviated 510(k) (1)](https://blog.scalehealth.com/tag/abbreviated-510k) - [administrative evaluation (1)](https://blog.scalehealth.com/tag/administrative-evaluation) - [medical device quality management system (1)](https://blog.scalehealth.com/tag/medical-device-quality-management-system) - [paperless quality processes (1)](https://blog.scalehealth.com/tag/paperless-quality-processes) - [qms Samd (1)](https://blog.scalehealth.com/tag/qms-samd) - [qms cloud (1)](https://blog.scalehealth.com/tag/qms-cloud) - [refuse-to-accept (1)](https://blog.scalehealth.com/tag/refuse-to-accept) - [rta letter (1)](https://blog.scalehealth.com/tag/rta-letter) - [special 510(k) (1)](https://blog.scalehealth.com/tag/special-510k) - [traditional 510(k) (1)](https://blog.scalehealth.com/tag/traditional-510k) See all ### Subscribe Here - ![sierra-labs](https://blog.scalehealth.com/hubfs/Sierralabs_January2019%20Theme/Images/sierra-labs-logo.png) - © 2022 Sierra Labs, Inc. - Contact Us - [hello@sierralabs.com](mailto:hello@sierralabs.com) - 3415 S. Sepulveda Blvd. Suite 1000 Los Angeles, CA 90034 - (310) 437-8010 - Products - Company - [About Us](https://www.sierralabs.com/about)